Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dimitrios Xourafas, M.D.

Concepts (104)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreaticoduodenectomy520205162.450 Why?
Pancreatectomy720218251.840 Why?
Pancreatic Fistula320201491.810 Why?
Hepatectomy420195881.210 Why?
Pancreatic Neoplasms9202154431.130 Why?
Laparoscopy6201820550.910 Why?
Drainage2201911840.840 Why?
Liver Neoplasms5201943630.730 Why?
Postoperative Complications92020158890.660 Why?
Smad4 Protein120191930.610 Why?
Diagnosis-Related Groups120184470.540 Why?
Failure to Thrive120161400.490 Why?
Cystadenocarcinoma, Mucinous12015510.480 Why?
Length of Stay5202065260.470 Why?
Dehydration120162160.470 Why?
Carcinoma, Pancreatic Ductal4202117560.460 Why?
Device Removal120196430.440 Why?
Patient Readmission2201833130.420 Why?
Laparotomy120154590.410 Why?
Hospital Costs120189590.400 Why?
Population Surveillance2201925970.380 Why?
Colorectal Neoplasms3201969820.360 Why?
Perioperative Care1201810450.360 Why?
Gastroplasty120121590.360 Why?
Adenocarcinoma, Mucinous120155260.360 Why?
Alanine Transaminase120126060.330 Why?
Carcinoma, Papillary120157930.330 Why?
Postoperative Care1201614810.330 Why?
Carcinoma, Hepatocellular2201823360.320 Why?
Neuroendocrine Tumors120156570.310 Why?
Cause of Death1201937210.300 Why?
Surgical Mesh120103160.290 Why?
Propensity Score3201919680.270 Why?
Hernia, Ventral120102200.270 Why?
Neoadjuvant Therapy6202129090.270 Why?
Neoplasm Staging52019112620.270 Why?
Intestinal Diseases120105050.250 Why?
Catheter Ablation1201927800.250 Why?
Vascular Surgical Procedures3201815150.240 Why?
Gastric Bypass120128240.220 Why?
Risk Assessment32019243330.210 Why?
Databases, Factual4201980940.200 Why?
Aged1520201717860.200 Why?
Obesity, Morbid1201213000.190 Why?
Middle Aged1620202237370.180 Why?
Postoperative Period2201518300.160 Why?
Suction120202680.160 Why?
Jaundice, Obstructive12018220.150 Why?
Retrospective Studies122021819030.150 Why?
Male1720203652030.150 Why?
Female1820213975150.140 Why?
Pancreatic Ducts120183300.130 Why?
Neoplasm Recurrence, Local1201594420.130 Why?
Treatment Outcome72018654800.130 Why?
Perioperative Period120172520.130 Why?
Intraoperative Care120197710.120 Why?
Aged, 80 and over52018597390.110 Why?
Neoplasms, Second Primary1202110600.110 Why?
Humans2020217689700.110 Why?
Costs and Cost Analysis1201816690.100 Why?
Logistic Models22018133180.100 Why?
Follow-Up Studies42019393940.100 Why?
Adult820192238510.100 Why?
Reoperation2201943420.090 Why?
Disease-Free Survival2201968560.090 Why?
Blood Transfusion1201813090.090 Why?
Neoplasm Invasiveness1201936290.090 Why?
Lymphatic Metastasis1201829160.090 Why?
Case-Control Studies22019222960.080 Why?
Diabetes Mellitus, Type 212012122530.080 Why?
Liver Cirrhosis1201819620.070 Why?
Intestinal Neoplasms120103140.070 Why?
Intestinal Obstruction120104330.070 Why?
Liver Transplantation1201824030.070 Why?
Risk Factors32018749760.070 Why?
Survival Analysis12019101150.060 Why?
Young Adult32018601310.060 Why?
Health Status1201840950.060 Why?
Prognosis32021300460.060 Why?
Analysis of Variance1201262360.060 Why?
Comorbidity12018105920.050 Why?
Adenocarcinoma1202164010.050 Why?
Disease Progression12019136740.050 Why?
United States32019731860.050 Why?
Age Factors12018184350.050 Why?
Weight Loss1201227210.050 Why?
Medicare1201868880.040 Why?
Insulin1201266100.040 Why?
Recurrence1201085130.040 Why?
Time Factors12019402610.030 Why?
Antineoplastic Agents12019136980.030 Why?
Mutation12019302660.030 Why?
Body Mass Index12012130550.030 Why?
Prospective Studies12019549620.030 Why?
Pancreas1202017000.030 Why?
Tomography, X-Ray Computed12015207760.020 Why?
Antineoplastic Combined Chemotherapy Protocols22021118860.020 Why?
Adolescent12017892440.020 Why?
Boston1202093770.020 Why?
Animals120191693350.020 Why?
Magnetic Resonance Imaging12015368540.020 Why?
Proportional Hazards Models12020125620.020 Why?
Survival Rate12019128730.010 Why?
Incidence12019215470.010 Why?
Xourafas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (104)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.